DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)
Financial Services • NASDAQ • $10.10+0.20%
- Symbol
- DMII
- Exchange
- NASDAQ
- Sector
- Financial Services
- Industry
- Shell Companies
- Price
- $10.10
- Daily Change
- +0.20%
- Market Cap
- $643.37M
- Trailing P/E
- 77.69
- Forward P/E
- N/A
- 52W High
- $10.10
- 52W Low
- $9.86
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Research DMII on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.